TrialJAMA dermatology2020

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial.

Kristian Reich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.